Clinical and microbiological characteristics of vancomycin-resistant enterococci with the vand phenotype and vana genotype

Japanese Journal of Infectious Diseases

Volumn 66, Issue 1, 2013, Pages 1-5

  Song, Joon Young ^a   Cheong, Hee Jin ^a   Seo, Yu Bin ^a   Kim, In Seon ^a   Heo, Jung Yeon ^a   Noh, Ji Yun ^a   Choi, Won Suk ^a   Kim, Woo Joo ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPEPTIDE; TEICOPLANIN; VANCOMYCIN; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; LIGASE; PEPTIDE SYNTHASE; VANA LIGASE, BACTERIA; VAND PROTEIN, ENTEROCOCCUS FAECIUM; VIRULENCE FACTOR;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ASA1 GENE; ASIAN; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CLINICAL ARTICLE; CLINICAL STUDY; CONTROLLED STUDY; CYLA GENE; ENTEROCOCCUS FAECIUM; ESP GENE; FEMALE; GELE GENE; GENOTYPE; HOSPITALIZATION; HUMAN; HYL GENE; INTENSIVE CARE; MALE; MICROBIOLOGICAL EXAMINATION; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; NONHUMAN; OUTCOME ASSESSMENT; PHENOTYPE; PULSED FIELD GEL ELECTROPHORESIS; RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT DURATION; VANA GENE; VANB GENE; VANCOMYCIN RESISTANT ENTEROCOCCUS; VAND GENE; CASE CONTROL STUDY; DRUG EFFECTS; GENETICS; GRAM POSITIVE INFECTION; INTENSIVE CARE UNIT; ISOLATION AND PURIFICATION; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; UNIVERSITY HOSPITAL; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CARBON-OXYGEN LIGASES; CASE-CONTROL STUDIES; ENTEROCOCCUS FAECIUM; FEMALE; GENOTYPE; GRAM-POSITIVE BACTERIAL INFECTIONS; HOSPITALS, UNIVERSITY; HUMANS; INTENSIVE CARE UNITS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PEPTIDE SYNTHASES; PHENOTYPE; RETROSPECTIVE STUDIES; RISK FACTORS; TEICOPLANIN; VANCOMYCIN; VANCOMYCIN RESISTANCE; VIRULENCE FACTORS;

EID: 84874778568     PISSN: 13446304     EISSN: 18842836     Source Type: Journal    
DOI: 10.7883/yoken.66.1     Document Type: Article

References (20)

1. Hayden, M.K. (2000): Insights into the epidemiology and control of infection with vancomycin-resistant enterococci. Clin. Infect. Dis., 31, 1058-1065.
2. Murray, B.E. (1997): Vancomycin-resistant enterococci. Am. J. Med., 102, 284-293.
3. Calfee, D.P., Giannetta, E.T., Durbin, L.J., et al. (2003): Control of endemic vancomycin-resistant Enterococcus among in- patients at a university hospital. Clin. Infect. Dis., 37, 326-332.
4. Matar, M.J., Tarrand, J., Raad, I., et al. (2006): Colonization and infection with vancomycin-resistant Enterococcus among patients with cancer. Am. J. Infect. Control, 34, 534-536.
5. Cheong, H.J., Song, J.Y., Eom, J.S., et al. (2002): Colonization rate, risk factor for acquisition and genetic diversity of van- comycin-resistant enterococci (VRE) isolated from rectal culture of patients in intensvie care units from ten large hospitals in Korea. Korean J. Infect. Dis., 34, 276-284.
6. Cetinkaya, Y., Falk, P. and Mayhall, C.G. (2000): Vancomycin- resistant enterococci. Clin. Microbiol. Rev., 13, 686-707.
7. Woodford, N. (2001): Epidemiology of the genetic elements responsible for acquired glycopeptide resistance in enterococci. Microb. Drug Resist., 7, 229-236.
8. Tenover, F.C., Arbeit, R.D., Goering, R.V., et al. (1995): Inter- preting chromosomal DNA restriction patterns produced by pul- sed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol., 33, 2233-2239.
9. Naas, T., Fortineau, N., Snanoudj, R., et al. (2005): First nosocomial outbreak of vancomycin-resistant Enterococcus faecium expressing a VanD-like phenotype associated with a vanA genotype. J. Clin. Microbiol., 43, 3642-3649.
10. Song, J.H., Ko, K.S., Oh, W.S., et al. (2006): High frequency of vancomycin-resistant Enterococcus faecium isolates with VanB phenotype and vanA genotype in Korean hospitals. Diagn. Microbiol. Infect. Dis., 56, 401-406.
11. Song, J.H., Ko, K.S., Suh, J.Y., et al. (2008): Clinical implications of vancomycin-resistant Enterococcus faecium (VRE) with VanD phenotype and vanA genotype. J. Antimicrob. Chemother., 61, 838-844.
12. Wikler, M.A. (2006): Performance standards for antimicrobial susceptibility testing: 16th informational supplement. Clinical and Laboratory Standards Institute, Wayne, Pa.
13. Vankerckhoven, V., Van Autgaerden, T., Vael, C., et al. (2004): Development of a multiplex PCR for the detection of asa1, gelE, cylA, esp, and hyl genes in enterococci and survey for virulence determinants among European hospital isolates of Enterococcus faecium. J. Clin. Microbiol., 42, 4473-4479.
14. Song, J.Y., Hwang, I.S., Eom, J.S., et al. (2005): Prevalence and molecular epidemiology of vancomycin-resistant enterococci (VRE) strains isolated from animals and humans in Korea. Korean J. Intern. Med., 20, 55-62.
15. Woodford, N. (1998): Glycopeptide-resistant enterococci: a de- cade of experience. J. Med. Microbiol., 47, 849-862.
16. Sakka, V., Tsiodras, S., Galani, L., et al. (2008): Risk-factors and predictors of mortality in patients colonised with van- comycin-resistant enterococci. Clin. Microbiol. Infect., 14, 14-21.
17. Tacconelli, E. and Cataldo, M.A. (2008): Vancomycin-resistant enterococci (VRE): transmission and control. Int. J. Antimicrob. Agents, 31, 99-106.
18. Worth, L.J., Slavin, M.A., Vankerckhoven, V., et al. (2008): Virulence determinants in vancomycin-resistant Enterococcus faecium vanB: clonal distribution, prevalence and significance of esp and hyl in Australian patients with haematological disorders. J. Hosp. Infect., 68, 137-144.
19. Dupre, I., Zanetti, S., Schito, A.M., et al. (2003): Incidence of virulence determinants in clinical Enterococcus faecium and En- terococcus faecalis isolates collected in Sardinia (Italy). J. Med. Microbiol., 52, 491-498.
20. Sedgley, C.M., Molander, A., Flannagan, S.E., et al. (2005): Virulence, phenotype and genotype characteristics of endodontic Enterococcus spp. Oral Microbiol. Immunol., 20, 10-19.